Powerful CO 167 Denial Code Fixes | Infusion Billing Services
How We Cut Repeat CO-167 Denials From 11% to 2.4% for an Infusion Practice
August 13, 2026
N30 Denial Code | Infusion Billing Services
How We Reduced N30 Denials by 78% and Recovered Delayed Payments
August 17, 2026
Powerful CO 167 Denial Code Fixes | Infusion Billing Services
How We Cut Repeat CO-167 Denials From 11% to 2.4% for an Infusion Practice
August 13, 2026
N30 Denial Code | Infusion Billing Services
How We Reduced N30 Denials by 78% and Recovered Delayed Payments
August 17, 2026

Beyond Claims Submission: How Infusion Billing Companies Improve Reimbursement and RCM

For an infusion practice, submitting a claim is not the finish line. It’s part of a revenue cycle process that starts with patient eligibility and authorization and then moves on to coding, claim adjudication, payment posting, denial processing, and follow-up on accounts receivable. Receipt of a claim that is on time and has poor financial results may happen when the drug code, units, service administration, modifiers, documentation or payer requirements do not match.

That is why an experienced Infusion Billing Company should be evaluated on more than how many claims it submits. The stronger question is whether its processes help a practice prevent avoidable denials, identify underpayments, control AR, reduce revenue leakage, and improve the amount of collectible revenue that ultimately becomes cash. This guide looks beyond claims submission to explain how specialized Infusion Billing Company  and RCM can improve reimbursement, where revenue commonly gets lost, and what practices should evaluate before choosing a billing partner.

 

Table of Contents

The 2026 Reality Behind Infusion Billing Companies

The need for specialized infusion billing companies is becoming more closely tied to financial performance in 2026. Infusion practices are operating within a payment environment where coding accuracy, drug pricing, administration services, documentation and payment requirements can directly impact reimbursement. CMS is still releasing and updating payment files and policies, such as 2026 payment rates for physician services, Part B drugs and home infusion therapy.

An incorrect bill, even in the case of expensive drugs, can cause a significant financial impact on the practice. Revenue may be delayed or funds uncollected due to an authorization that was not received, the wrong number of units were authorized, or payment was not received for the amount stipulated in the contract. The more the same error is found in dozens or hundreds of claims, the bigger the problem becomes.

In 2026 the reality is not just that there’s a need for someone to process claims faster when it comes to infusion. They must have a revenue cycle capability that integrates clinical documentation, coding, payer requirements, reimbursement analysis and collections

 

Why Traditional Claims Processing Is No Longer Enough

A traditional claims workflow may focus heavily on whether a claim was created and transmitted successfully. That is important, but it does not answer several financial questions that an Infusion Billing Company should address:

  • Was the correct drug and administration service reported?
  • Were the units supported by the documentation?
  • Was the required authorization obtained and matched to the service?
  • Did the payer apply the expected reimbursement methodology?
  • Was a denied claim appealed for the right reason?
  • Was an underpayment identified rather than written off?
  • Is a recurring denial pointing to a workflow problem?

An Infusion Billing Company that addresses these questions can move from transactional billing to active revenue cycle management.

 

Why Payer and Payment Changes Matter

Infusion reimbursement is also affected by changes in payment policies and drug pricing. According to CMS, Average Sales Price is the predominant pricing model used for many separately payable Part B drugs and CMS pays separately for drug administration. CMS also provides contractors with updated payment and pricing files to help them calculate payment limits. In an infusion practice, this translates to reimbursement is not a set number. There should be processes in place to ensure that coding, payer rules, payment expectations and follow up on claims remain synchronized with the current requirement. Practices could otherwise fall behind on regulatory changes if they don’t have an Infusion Billing Company that actively tracks them.

 

What an Infusion Billing Company Actually Does

An Infusion Billing Company is a company that runs the monetary aspect of infusion services throughout the revenue phases of the RCM. Its work can start prior to the patient getting treated and may extend beyond when the claim is processed by the payer.

At the front end, this could be eligibility verification, benefits investigation, authorization coordination, and determining if the proposed service is covered by the payers. As part of charge capture and coding, the Infusion Billing Company ensures that the drug, dosage, units, administration services modifiers, place of service and supporting documentation are all properly reported. Once submitted, the work moves on to payment posting, denial management, AR follow-up, appeal, and reimbursement analysis. It’s the value to be gained from tying these activities together, not from the individual tasks themselves

 

Where Infusion Revenue Gets Lost Before Payment

Many times revenue leakage begins before the claim gets to an insurer. Even if a practice provides a medically necessary infusion and it never gets the reimbursement it is owed because of a billing or other error in the process that could have been avoided.

Common sources include:

  • Incorrect drug or administration coding
  • Incorrect dosage or unit reporting
  • Missing or inappropriate modifiers
  • Authorization mismatches or missing authorization
  • Eligibility and benefit verification errors
  • Documentation that does not support the billed service
  • Incorrect place of service
  • Timely filing failures
  • Payer-specific billing requirements that were overlooked
  • Charges that were never captured or submitted

The financial impact becomes more significant when the affected service involves a high-cost drug. A coding mistake on a low-dollar office service may be inconvenient. A similar mistake on an expensive infusion claim can create a much larger reimbursement gap.

 

From Coding Error to Revenue Leakage

Let’s take the basic problem of a workflow. A patient is infused and the dosage written on the claim is not consistent with the units noted on the claim. The payer can refuse to cover the drug line, ask the practice to provide more information, or pay a different sum to the practice than originally requested. If the problem is addressed after the claim is denied, the company has wasted staff time and denied the employee timely payment.

Now multiply that problem by a persistent drug, provider, payer or location. One coding mistake is replaced by a multiple revenue leakage issue. This is where RCM analysis can be used more effectively than claim correction alone. The goal isn’t just to resolve the denied claim. The purpose of the error is to determine the reason it has occurred, if the error has occurred again, which payer, which service line is the error impacting, and what workflow change will help make the error go away again.

 

How Infusion Billing Companies Improve Claim Accuracy

Accurate claims begin with accurate information. A specialized billing team of an infusion billing company can create pre-billing checks designed around the specific risks found in infusion services.

These checks may include verification of:

  • Patient and insurance information
  • Authorization status and approved services
  • Drug and HCPCS or J-code selection
  • Dosage and billing units
  • Administration codes
  • Modifiers
  • Place of service
  • Documentation requirements
  • Medical necessity support
  • Payer-specific claim rules

The goal is to identify errors before the claim reaches the payer rather than relying on the payer’s denial process to identify them later.

 

How Infusion Billing Companies Improve Reimbursement Beyond Clean Claims

Improving reimbursement requires looking at the difference between what was billed, what was expected, what the payer allowed, and what the practice actually received. This is where specialized RCM moves beyond basic claim processing. An Infusion Billing Company can assist practices in reviewing payment patterns, identifying discrepancies, investigating underpayments, and determining if the practice is experiencing repeated reimbursement problems. If there is a repetition between the underpayments and a specific payer, drug, service, or contract.

Finding Underpayments That Standard Billing Misses

An underpayment may not generate a denial. The payer may process the claim and issue a payment, which can make the transaction appear complete. But if the payment is below the expected reimbursement, the practice may still have recoverable revenue. A stronger reimbursement workflow compares expected payment with actual payment and investigates material variances. Depending on the payer arrangement and applicable rules, this can involve reviewing allowed amounts, drug reimbursement, administration payment, contractual terms, bundling decisions, and other adjudication details.

The key principle is simple: a paid claim is not automatically a correctly paid claim.

 

How Infusion Billing Companies Manage Denials

There are several points in the revenue cycle where denials for infusion may occur. If the problem is treated as a simple billing problem, the recovery process may take longer and the issue may not be solved. When it comes to denials, common types are authorization denials, eligibility and coverage denials, medical necessity denials, drug coding and unit denials. The best starting point is categorization. After grouping denials, the practice can find out whether the issue is authorization, clinical documentation, coding, claim submission, payer processing, follow-up, or any other reason.

 

Turning Denial Management Into Prevention

Denial management is not complete with appeal. In a robust RCM, denial trends are monitored and the question is asked if the same issue is occurring in several claims. A mismatch in authorizations can be a problem for a payer if they repeatedly decline the same drug when it comes in for a claim to be processed. A drug unit issue that occurs frequently may require a charge-capture or coding correction. There may be a need to review the clinical documentation process if documentation requests are occurring regularly. This root cause approach is not rework, but operational improvement based on denial data.

 

How Infusion Billing Companies Strengthen End-to-End RCM

The front-end and back-end processes work best when linked together in the revenue cycle management. An end-to-end infusion RCM workflow can involve patient registration, eligibility verification, benefits investigation, prior authorization coordination, charge capture and coding. Also claim submission, payment posting, denial management, AR follow-up, underpayment investigation and financial reporting.

The advantage is visibility. A problem identified in AR can be traced back to its likely source. A denial trend can be connected to a payer or workflow. A reimbursement variance can be investigated instead of disappearing into a write-off category.

 

Connecting Front-End and Back-End RCM

Front-end mistakes often become back-end collection problems. An authorization issue can produce a denial weeks after treatment. An eligibility error can create a patient balance that could have been avoided with earlier verification. A documentation gap can delay an appeal. A coding error can cause repeated rework across the billing team. An Infusion Billing Company that connects these stages can help practices address the cause rather than repeatedly managing the consequence.

 

Using RCM Data to Improve Financial Performance

Use a starting point. Find out the current denial patterns, AR aging, collection performance and payment variance. Then identify the highest-impact problem rather than trying to fix every process simultaneously.

For example, if authorization-related denials account for a large share of lost reimbursement, improving claim scrubbing alone will not solve the problem. If AR is concentrated with a small number of payers, payer-specific follow-up may produce a greater financial impact than increasing general billing volume.

This is where RCM reporting becomes a management tool rather than a monthly status report.

 

When an Infusion Practice Needs Specialized Billing Support

This choice will depend on the size of the practice, its staffing, its payer mix, its technology, and the expertise of its staff. There must be a measurable problem that an outsourced Infusion Billing Company can address.

  • Increasing denial rates
  • Growing aged AR
  • Delayed reimbursement
  • Frequent authorization problems
  • High-cost drug claims with payment discrepancies
  • Internal staff struggling with billing volume or complexity
  • Limited visibility into payer performance
  • Repeated coding or documentation errors
  • Difficulty keeping up with payer policy changes
  • Expansion into additional infusion services and locations

The question is not simply whether the practice has a billing team. It is whether the existing process consistently protects collectible revenue without placing an unsustainable administrative burden on clinical and management staff. An Infusion Billing Company can provide that support.

 

In-House Billing vs an Infusion Billing Company

Practice Factor In-House Billing Specialized Infusion Billing Company
Infusion coding expertise Depends on internal staff Dedicated specialty expertise may be available
Payer rule monitoring Internal responsibility Structured monitoring process
Denial management Limited by staff capacity Dedicated denial workflows
AR follow-up Depends on available resources Dedicated follow-up capacity
Underpayment detection May be inconsistent Can be systematically reviewed
RCM reporting Varies by practice Performance-focused reporting
Scalability May require additional staff Can scale with billing volume

The right choice depends on the practice’s volume, staffing, payer mix, technology, and internal expertise. Outsourcing to an Infusion Billing Company should solve a measurable operational or financial problem, not simply move tasks from one inbox to another.

 

How to Evaluate an Infusion Billing Company

When comparing vendors, practices should look beyond promises of faster claims. A strong evaluation should examine whether the Infusion Billing Company understands the financial and coding complexity of infusion services.

Consider these factors when evaluating an Infusion Billing Company:

  • Infusion-specific billing experience
  • Specialty drug reimbursement knowledge
  • Coding and compliance expertise
  • Authorization and eligibility support
  • Denial prevention and appeal processes
  • AR management capabilities
  • Underpayment recovery
  • Payer-specific expertise
  • RCM reporting
  • Technology and claim validation tools
  • HIPAA-compliant workflows and data security
  • Communication procedures
  • Relevant performance metrics

 

Questions to Ask Before Hiring an Infusion Billing Company

Before signing an agreement, ask practical questions rather than relying on general sales claims:

  1. How do you validate infusion drug units and administration codes?
  2. How do you identify authorization-related risks before claims are submitted?
  3. How do you manage recurring payer-specific denials?
  4. How do you identify and recover underpayments?
  5. Which RCM KPIs will you report regularly?
  6. How do you prioritize aged AR?
  7. How do you distinguish a claim correction from a root-cause problem?
  8. How will our team receive updates on denials, AR, and reimbursement trends?
  9. How do you protect patient information and maintain compliant workflows?
  10. What does your implementation and transition process look like?

The answers reveal whether a prospective Infusion Billing Company operates as a billing processor or as a strategic RCM partner.

 

Top Performing Companies to Consider for Infusion RCM

Choosing an infusion RCM partner requires more than comparing service lists. Practices should evaluate specialty expertise, payer knowledge, denial management, reporting, and revenue cycle support.

Company Key Infusion RCM Strength Best Fit
Billing Care Solutions End-to-end RCM, denial management, A/R, coding, and authorization support Infusion practices seeking comprehensive revenue cycle management
Infusion Billing Services Infusion-focused billing, coding, authorization, and reimbursement support Practices needing specialized infusion billing expertise

Billing Care Solutions

Billing Care Solutions offers infusion provider end-to-end RCM solutions. This encompasses Eligibility Verification, Prior Authorization, Coding, Claim Submission, Denial Management, A/R Follow-Up and Payment Analysis. Its strategy aligns front-end billing controls with revenue performance. This enables practices to detect where authorizations are missing, where coding is incorrect, where there are payor problems, and where there are collection issues, sooner.

 

Infusion Billing Services

Infusion Billing Services specialize in the billing and revenue cycle processes of infusion practices. It has a specialty emphasis of drug billing, infusion administration, payer requirements and reimbursement workflows.  Any practice looking at these companies should consider checking their specialty expertise, their experience with payers, their denial prevention and their authorization management, as well as reporting and measurable revenue cycle outcomes.

 

What to Compare Before Signing a Contract

The strongest vendor comparison should move beyond a feature checklist. Ask each Infusion Billing Company to explain how it would respond to the practice’s actual RCM data. For example, if the practice has a high authorization denial rate, ask for the proposed prevention workflow. If aged AR is increasing, ask how accounts would be prioritized and escalated. If paid claims appear to be under-reimbursed, ask how payment variance would be identified. If drug-unit errors are recurring, ask where the Infusion Billing Company would place the validation control.

This method translates the comparison into a financial figure. The practice can look for an Infusion Billing Company that has a streamlined process for addressing the greatest value issues rather than the company that has the longest list of services.

 

How Infusion Billing Services Supports Better RCM

A specialized partner can be an infusion practice’s best asset in terms of linking out billing information with financial results. According to Infusion Billing Services, the company can handle charge capture, coding, clean claims, denial management, payer follow-up, aging AR monitoring, performance tracking and reporting for infusion providers.

This is the main concept of an efficient infusion RCM: Improving reimbursement is not about submitting claims to the insurance company. It is based upon regulating the actions and inactions that affect a claim’s accuracy, payability, proper adjudication and correct payment, as well as its subsequent execution in case of missteps.

If outsourcing is in the consideration list, the best starting point is to review existing practices and current performance. The goal is to determine what revenue is being lost or deferred, develop measurable KPIs and set up a mechanism for continually enhancing performance.

 

Final Takeaway

An Infusion Billing Company can’t be evaluated by the amount of claims that it submits. Infusion reimbursement relies on a much larger system, with eligibility, authorization, documentation, coding, drug units, administration services, drug payer rules, denial management, AR follow-up and payment analysis. That wider lens is becoming more significant in 2026. CMS is continually changing payment data and drug pricing files, and infusion practices need to ensure their billing practices continue to reflect evolving reimbursement and documentation needs. An expert Infusion Billing Company saves you from such changes by keeping your practice up to date.

One of the financial decisions that your practice will make is the choice of the right Infusion Billing Company. Infusion Billing Services can be assessed as a dedicated infusion billing and RCM partner for practices that require a specialized infusion billing expert. A final determination should be made based on proven knowledge, clear communication, and experience with payers, security and compliance measures, and actual financial results.

 

Frequently Asked Questions

What makes infusion billing different from other billing?

Infusion billing includes the costs of expensive drugs, complicated J-codes, site of service regulations, and documentation requirements. Typical medical billers don't have this knowledge.

Why do infusion claims get denied so often?

The most common reason for infusion claims being denied is either a lack of prior authorization, drug coding issues, lack of medical necessity documentation, timely filing issues, or mismatches in the payer's policy.

How can an infusion billing company reduce denials?

A dedicated company reviews authorizations, validates drug codes, reviews documentation, and scrub claims prior to submission and monitors payer rules to avoid common claims errors.

What should I look for in an infusion billing partner?

Look out experience with your payer mix, transparent reporting, AR follow-up systems, denial management processes, and proven infusion coding expertise.

Can outsourcing infusion billing improve my cash flow?

Outsourcing speeds up cash flow by reducing the time to claim, denials, systematic AR follow up, and by having dedicated teams that chase over-due payments.

How do infusion billing companies handle prior authorizations?

They confirm coverage, secure authorizations prior to treatment, monitor authorization expiration dates, and handle reauthorization to avoid high cost infusion claim denials.

What are the most common infusion coding mistakes?

Typical errors are selecting a wrong J-code, using the wrong dosage unit, failure to use modifiers, wrong place of service, and documentation not supporting the billed service.

How do I measure infusion billing company performance?

Monitor your billing partner's performance with track clean claim rate, denial rate, days in AR, net collection rate, appeal success rate and underpayment recovery data.

Is in-house billing better than hiring an infusion company?

While in-house billing can be effective with smaller quantities, specialized firms have a higher level of expertise, knowledge of payers, and denial management without the hassle of additional staff members.

What does an infusion billing company cost my practice?

Charges will be different depending on the percentage of collections, number of claims or a fixed fee per claim. Most companies impose a percentage fee of the revenue they have collected and so they are on a performance basis.